IP Library › Granted Patent US 11,135,315
Granted Patent B2
US 11,135,315 · App. 16/295,774 · Granted Oct 5, 2021

Composition for detecting biofilms on viable tissues

Inventors: Phillip Godfrey Bowler (Flintshire, GB); Daniel Gary Metcalf (Flintshire, GB); David Parsons (Flintshire, GB); Emily Sonia Johnson (Flintshire, GB)
Assignee: CONVATEC TECHNOLOGIES INC.
A61K49/0041C12Q1/04G01N33/533G01N33/569G01N33/582
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 11,135,315
App. No.
16/295,774
Granted
Oct 5, 2021
Kind
B2
Abstract

A staining composition for use in making biofilm detectable on viable tissue wherein the composition preferentially stains the biofilm and comprises a staining agent in a quantity effective to stain the biofilm and render it detectable.

Claims (32)

1. A staining composition for use in making biofilm detectable on viable tissue that preferentially stains the biofilm rather than the viable tissue, the composition comprising:

a staining agent in a quantity effective to stain the biofilm and render the biofilm detectable, wherein the staining agent is Rose Bengal,

0.1 to 2.0% by weight EDTA,

0.1 to 1.0% by weight of a surfactant, and

a preservative in the form of methyl-paraben to provide preservative action in the composition,

wherein the composition is a non-gelled composition, and

wherein the composition is in the form of a lyophilized wafer.

2. A composition as claimed in claim 1 , wherein the composition preferentially stains the biofilm by selectively binding to the biofilm rather than the viable tissue.

3. A composition as claimed in claim 1 , wherein the composition allows detection of the biofilm by preferentially staining and revealing to the naked eye.

4. A composition as claimed in claim 1 , wherein the composition allows detection of the biofilm by preferentially staining the biofilm with a staining agent which is capable of fluorescence.

5. A composition as claimed in claim 1 , wherein the staining agent absorbs light of wavelengths from 380 nm to 720 nm.

6. A composition as claimed in claim 1 , wherein the composition allows the detection of the biofilm by preferentially staining and revealing the biofilm when the biofilm is illuminated with light including wavelengths that cause the biofilm to fluoresce.

7. A composition as claimed in claim 6 , wherein the fluorescence is detectable with the naked eye or a light source and optical filters corresponding to the fluorescence emission spectra of the staining agent.

8. A composition as claimed in claim 1 , wherein the composition comprises a humectant.

9. A composition as claimed in claim 1 , wherein the composition comprises from 0.0001% to 1% by weight of Rose Bengal.

10. A kit of parts for use in the detection of biofilms on viable tissue, the kit comprising:

a composition including a staining agent which preferentially stains biofilms, 0.1 to 2.0% by weight EDTA, 0.1 to 1.0% by weight of a surfactant, and a preservative to provide preservative action in the composition, wherein the staining agent is Rose Bengal, wherein the composition is a non-gelled composition, wherein the composition is in the form of a soluble film, and wherein the preservative includes methyl-paraben, and

a light source capable of causing the staining agent to fluoresce.

11. A kit as claimed in claim 10 , wherein the light source emits light in order to make the staining agent fluoresce.

12. A kit as claimed in claim 10 , comprising spectacles or lenses for use in detecting the biofilm wherein the spectacles or lenses act to exclude all wavelengths of light except those at which the staining agent fluoresces.

13. A kit as claimed in claim 10 , comprising a wound irrigation solution.

14. A method of detecting a biofilm in a wound comprising:

obtaining a non-gelled composition including a staining agent which preferentially stains biofilms, 0.1 to 2.0% by weight EDTA, 0.1 to 1.0% by weight of a surfactant, and a preservative in the form of methyl-paraben, wherein the staining agent is Rose Bengal;

terminally sterilizing the composition using ethylene oxide;

applying the composition to viable tissue;

inspecting the tissue for the presence of stained biofilm with the naked eye or with a light source that causes the stained biofilm to fluoresce; and

detecting the fluorescence emitted from the stained biofilm.

15. The method of claim 14 , wherein the composition is a foaming mousse and includes a foaming agent.

16. The method of claim 14 , wherein the composition is a soluble film.

17. The method of claim 14 , wherein the composition is a lyophilized wafer.

18. The method of claim 14 , wherein applying the composition to viable tissue comprises (i) contacting the viable tissue with a soluble film including the composition that has a thickness of at least 0.1 centimeter and (ii) leaving the soluble film in place for at least 2 minutes to permit dissolution of the film.

19. The method of claim 14 , wherein applying the composition to viable tissue comprises (i) contacting the viable tissue with a lyophilized wafer including the composition that has a thickness of at least 0.1 centimeter and (ii) leaving the lyophilized wafer in place for at least two minutes to permit dissolution of the wafer.

Assignments (1)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Mar 8, 2019
From: BOWLER, PHILLIP GODFREY; METCALF, DANIEL GARY; PARSONS, DAVID; JOHNSON, EMILY SONIA
To: CONVATEC TECHNOLOGIES INC.
Reel/Frame 048543/0635 →
Priority Claims (1)
GB 1020236 · Nov 30, 2010 · national
Continuity (2)
Continuation 13990755
Related Publication 20190216953A1 · Jul 18, 2019